[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 28, 2012

Toward a Harmonized and Centralized Conflict of Interest DisclosureProgress From an IOM Initiative

Author Affiliations

Author Affiliations: American Society of Clinical Oncology, Alexandria, Virginia (Dr Lichter); and Department of Pediatrics and Trent Center for Bioethics, Humanities, and History of Medicine, Duke University School of Medicine, Durham, North Carolina (Dr McKinney).

JAMA. 2012;308(20):2093-2094. doi:10.1001/jama.2012.51172

The 2009 Institute of Medicine (IOM) report Conflict of Interest in Medical Research, Education, and Practice1 recognized the benefits that accrue when physicians and researchers collaborate with companies in the biomedical industry. Because the committee also recognized that certain financial ties can unduly influence professional judgment, it proposed a series of recommendations to help manage conflicts of interest (COIs). The core of those management strategies relies on the disclosure of relationships between individual researchers and the relevant companies.

First Page Preview View Large
First page PDF preview
First page PDF preview